Update in medical therapy of ulcerative colitis - Newer concepts and therapies

被引：13

作者：

Katz, S

机构：

[1] NYU, Sch Med, Dept Med, New York, NY USA

[2] N Shore Univ Hosp, Long Isl Jewish Hlth Syst, Manhasset, NY USA

[3] St Francis Hosp, Roslyn, NY USA

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2005年 / 39卷 / 07期

关键词：

inflammatory bowel disease; ulcerative colitis;

D O I：

10.1097/01.mcg.0000170735.43887.3a

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Recent advances in the pathogenesis of ulcerative colitis recognize the interface of genetic susceptibility, environmental factors (eg, gut microflora), and an altered host's immune response. The meteoric evolution of new therapies designed to address these pathogenetic factors may lead to confusing and often confounding treatment programs. This review is designed to assist the practitioner when incorporating new or novel therapies into a treatment program. These decisions are based on new clinical trial data and the experience of seasoned gastroenterologists with established remedies.

引用

收藏

页码：557 / 569

页数：13

相关论文

共 157 条

[1]

Abdelrazeq AS, 2004, GASTROENTEROLOGY, V126, pA628

[2] Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis [J].

Actis, GC ;

Bresso, F ;

Astegiano, M ;

Demarchi, B ;

Sapone, N ;

Boscaglia, C ;

Rizzetto, M .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) :1307-1311

[3] Predictors of chronic pouchitis [J].

Al-Haddad, M ;

Achkar, JP ;

Connor, J ;

Remzi, F ;

Shen, B ;

Brzezinski, A ;

Lashner, B ;

Fazio, V .

GASTROENTEROLOGY, 2003, 124 (04) :A37-A37

[4] Left-sided ulcerative colitis: True extent of disease and risk of pouchitis [J].

Alkoraishi, A ;

Wolff, BG ;

Smyrk, TC ;

Tremaine, WJ .

GASTROENTEROLOGY, 2003, 124 (04) :A218-A218

[5] Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease [J].

Ang, YS ;

Mahmud, N ;

White, B ;

Byrne, M ;

Kelly, A ;

Lawler, M ;

McDonald, GSA ;

Smith, OP ;

Keeling, PWN .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1015-1022

[6] Azathioprine is more effective than oral 5-ASA in the treatment of steroid-dependent ulcerative colitis. [J].

Ardizzone, S ;

Samolvico, F ;

Bollani, S ;

Imbesi, V ;

Colombo, E ;

Porro, GB .

GASTROENTEROLOGY, 2001, 120 (05) :A127-A127

[7]

ARMUZZI A, 2001, GASTROENTEROLOGY, V126, pT1297

[8] Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis [J].

Bar-Meir, S ;

Fidder, HH ;

Faszczyk, M ;

Porro, GB ;

Sturniolo, GC ;

Mickisch, O ;

Müller, R ;

Greinwald, R ;

Chowers, Y ;

Gross, V .

DISEASES OF THE COLON & RECTUM, 2003, 46 (07) :929-936

[9] Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? [J].

Bernstein, CN ;

Metge, C ;

Blanchard, JF ;

Yogendran, M .

GASTROENTEROLOGY, 2003, 124 (04) :A36-A36

[10] Optimal Dosing of 5-Aminosalicylic Acid: 5 Decades of Choosing Between Politicians [J].

Bickston, Stephen J. ;

Cominelli, Fabio .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (01) :3-4

← 1 2 3 4 5 6 7 8 9 10 →